XML 36 R24.htm IDEA: XBRL DOCUMENT v2.4.1.9
EQUITY COMPENSATION (Tables)
3 Months Ended
Mar. 31, 2015
Equity Compensation  
Schedule of compensation expense and tax benefits for stock-based awards and programs

We recognized the following amounts in compensation expense and tax benefits for all of our stock-based awards and programs for the applicable periods ended March 31 (in thousands):

 

 

 

Three Months Ended

 

Twelve Months Ended

 

 

 

2015

 

2014

 

2015

 

2014

 

Compensation expense

 

$

742 

 

$

1,349 

 

$

3,081 

 

$

2,636 

 

Tax benefit recognized

 

271 

 

502 

 

1,127 

 

955 

 

 

Schedule of time vested restricted stock activity

 

 

 

2015

 

2014

 

 

 

 

 

Weighted

 

 

 

Weighted

 

 

 

Number of

 

Average Fair

 

Number of

 

Average Fair

 

 

 

shares

 

Market Value

 

shares

 

Market Value

 

Outstanding at January 1,

 

41,000

 

$

21.89

 

24,900

 

$

22.68

 

Granted

 

19,000

 

30.40

 

22,600

 

22.40

 

Vested

 

(1,654

)

21.92

 

710

 

24.29

 

Distributed

 

 

 

 

 

(3,300

)

22.98

 

Forfeited

 

(2,746

)

25.91

 

(2,490

)

 

Vested but not distributed

 

1,654

 

21.92

 

(710

)

 

Outstanding at end of period

 

57,254

 

$

24.81

 

41,710

 

$

21.89

 

 

Schedule of non-vested performance-based restricted stock awards (based on target number) and changes during the reporting period

 

 

 

2015

 

2014

 

 

 

Number
of shares

 

Weighted Average
Grant Date Price

 

Number
of shares

 

Weighted Average
Grant Date Price

 

Outstanding at January 1,

 

63,300

 

$

21.74

 

47,200

 

$

21.39

 

Granted

 

21,800

 

$

30.40

 

27,000

 

$

22.40

 

Awarded

 

(13,653

)

$

30.55

 

 

 

Awarded in excess of target

 

3,653

 

$

30.55

 

 

 

Not awarded

 

0

 

$

0

 

(10,900

)

$

21.84

 

Granted, nonvested at March 31,

 

75,100

 

$

24.36

 

63,300

 

$

21.74

 

 

Schedule of stock options activity

 

 

 

2014

 

 

 

 

 

Weighted Average

 

 

 

Options

 

Exercise Price

 

Outstanding at January 1,

 

112,500 

 

$

23.27 

 

Granted

 

 

 

Exercised

 

48,300 

 

$

23.70 

 

Outstanding at March 31,

 

64,200 

 

$

23.81 

 

Exercisable at March 31,

 

64,200 

 

$

23.81